ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,6,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,8,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
2,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
